The influence of the patients' educational levels on socioeconomic, clinical, immunological and virological endpoints (Q46097976)

19 December 2017

title

The influence of the patients' educational levels on socioeconomic, clinical, immunological and virological endpoints (English)

1 reference

19 December 2017

0 references

1 reference

Julio Collazos

1

1 reference

19 December 2017

Víctor Asensi

2

1 reference

19 December 2017

José Antonio Carton

3

1 reference

19 December 2017

Sofía Ibarra

4

1 reference

19 December 2017

Grupo Español para el Estudio Multifactorial de la Adherencia

5

1 reference

19 December 2017

publication date

1 April 2009

1 reference

19 December 2017

published in

AIDS Care

1 reference

19 December 2017

volume

21

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

511-519

1 reference

19 December 2017

Is it possible to reduce AIDS deaths without reinforcing socioeconomic inequalities in health?

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Comparison of health status, socioeconomic characteristics, and knowledge and use of HIV-related resources between HIV-infected women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Risk factors for overdose mortality: a case-control study within a cohort of intravenous drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

The urban built environment and overdose mortality in New York City neighborhoods

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Impact of socioeconomic status on survival with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

The impact of childhood living conditions on illness and mortality in adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Greater effect of highly active antiretroviral therapy on survival in people aged > or =50 years compared with younger people in an urban observational cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy. Lazio AIDS Surveillance Collaborative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Trends and characteristics of AIDS mortality in the Rio de Janeiro city after the introduction of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

All-cause and cause-specific death rates by educational status for two million people in two American Cancer Society cohorts, 1959-1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Survival in HIV infection: do sex and category of transmission matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Social health inequalities during the course of chronic HIV disease in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

Lack of legal income is strongly associated with an increased risk of AIDS and death in HIV-infected injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802270300

10.1080/09540120802270300

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

19266411

1 reference

19 December 2017